NCT06691100

Brief Summary

This study aims to elucidate the differences in the gut microbiome functional activity and metabolome in adult premenopausal women with distinctive fitness levels and BMIs (with obesity, w/o obesity). The specific aims are as follows:

  • Aim 1: To examine the effects of acute aerobic exercise at 60-70% heart rate reserve (HRRmax) for 30 minutes bout on changes in the abundance of SCFA-producing bacteria and their functional downstream metabolic activity.
  • Aim 2: To examine the effects of acute aerobic exercise at 60-70% HRRmax 30-minute bout on changes in GM-released SCFA concentrations in stool and plasmatic metabolome.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
18mo left

Started Oct 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Oct 2024Oct 2027

Study Start

First participant enrolled

October 16, 2024

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

November 12, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 15, 2024

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 16, 2027

Last Updated

July 24, 2025

Status Verified

July 1, 2025

Enrollment Period

2.6 years

First QC Date

November 12, 2024

Last Update Submit

July 22, 2025

Conditions

Keywords

Gut MicrobiotaWomens HealthExerciseWeight ManagementObesity

Outcome Measures

Primary Outcomes (4)

  • Gut Microbiome Composition

    Shotgun metagenomics will be used to examine the abundance of specific SCFA-producing bacteria in the stool (e.g., Ruminococcus)

    Before the exercise intervention and immediately after the intervention

  • Gut Microbiome Function

    Shotgun metagenomics will be used to examine the BGCs (i.e., the genes within the microbial genome that dictate gut microbial functionality) to investigate functional downstream metabolic activity.

    Before the exercise intervention and immediately after the intervention

  • Plasma Metabolome

    Gas chromatography and mass spectrometry will be used to measure concentrations of SCFAs in plasma before and after the exercise intervention

    Before the exercise intervention, immediately after the exercise intervention, and 24 hours before the intervention

  • Stool Metabolome

    Gas chromatography and mass spectrometry will be used to measure concentrations of SCFAs in stool before and after the exercise intervention

    Before the exercise intervention, immediately after the exercise intervention, and 24 hours before the intervention

Study Arms (1)

Intervention

EXPERIMENTAL

30-minute exercise bout in a cycle ergometer at 60 to 70% of the Heart Rate Reserve (HRR) and corresponding power (watts).

Behavioral: Aerobic Exercise

Interventions

30-minute exercise bout in a cycle ergometer at 60 to 70% of the Heart Rate Reserve (HRR) and corresponding power (watts).

Intervention

Eligibility Criteria

Age21 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsSex assigned at birth: Female
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Biological sex: female
  • BMI 19 to 24.99 kg/m2 or BMI 30-40 kg/m2
  • Exercisers: Exercise at least 4 times per week for 60 minutes (a total of 240 minutes per week) on a programmed exercise training either on endurance sports (e.g., running, cycling, triathlon), strength (e.g., powerlifting), or team sports (e.g., rugby, football, soccer)
  • Non-Exercisers: Sedentary individuals who have not reached the PA guidelines (150 minutes of moderate-intensity physical activity a week, 75 minutes of vigorous-intensity physical activity, or an equivalent combination of moderate and vigorous-intensity physical activity).

You may not qualify if:

  • Biological sex: male
  • BMI \< 19 kg/m2 or \> 40 kg/m2
  • Currently pregnant, \< 2 years postpartum, lactating
  • Currently taking any herbal, fiber, or prebiotic supplement
  • Current or 1-month before the study, taking oral or vaginal antibiotics
  • Diagnosed with any gastrointestinal, endocrine, digestive, cancer, or cardiovascular disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Milken Institute School of Public Health, The George Washington University

Washington D.C., District of Columbia, 20037, United States

RECRUITING

Related Links

MeSH Terms

Conditions

ObesityMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Carmen Ortega-Santos, PhD, RD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 12, 2024

First Posted

November 15, 2024

Study Start

October 16, 2024

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

October 16, 2027

Last Updated

July 24, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

We will not be sharing individual participant data (IPD) for this study. Protecting participant privacy is a priority; even de-identified data carries a risk of re-identification, particularly in a smaller sample.

Locations